This article explores how advances in antibody engineering are moving immunotherapy beyond traditional monoclonal antibodies to bispecific and trispecific formats and logic-gated designs.

Antibodies made by the immune system can sometimes target human brain cells, producing psychiatric symptoms. Researchers aim ...

Why Global Top‐Tier Teams Choose Chinese Research‐Reagent Brand?. Rigorous validation in metabolism, oncology immunology and gut‐brain‐axis research proves Cloud‐Clone antibodies' global‐competitive ...

C difficile colonization in infants has long been assumed to be harmless, but Joseph Zackular, PhD, researcher in the ...

Zolbetuximab has been hailed as one of the most consequential additions to gastric cancer therapy in a generation. The ...

“Our liberty depends on the freedom of the press, and that cannot be limited without being lost.” — Thomas Jefferson “If we ...

One of the hallmark characteristics of Alzheimer’s disease is the abnormal accumulation of amyloid-beta protein in the brain.

Syndax achieved FDA approval for Revuforj in r/r mNPM1 AML and is pursuing pivotal studies to expand into 1st-line AML ...

A clinical trial called "PARTNERS" is evaluating Infusion of MBP134, a monoclonal antibody cocktail, Infusion of Remdesivir, and Infusion of both, as a treatment for Ebola BDBV infection against ...

Parkinson’s disease is defined by the slow, relentless spread of a misfolded protein called alpha-synuclein through the brain ...

Find out how different vaccines for the coronavirus cause your body to create antibodies that fight the virus.